CLINICAL_TRIALS
withdrawal
· 2025-08-29
Clinical Trial Update: MOLecular Characterization and Treatment of THYroid Carcinoma on Struma Ovarii
Summary
A clinical trial investigating molecular characterization and treatment of thyroid carcinoma arising in struma ovarii (ovarian cancer) was withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Institut Bergonié | Conditions: Ovarian Cancer | Status: WITHDRAWN